Neurocrine Biosciences's chart data is dated 2026-10-08. There is no active technical signal. There are 4 published signal records.
Neurocrine Biosciences last closed at $141.25 (-1.55%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 20.9×. Its overall grade ranks 206 of 738 stocks in Healthcare.
About this company
Neurocrine Biosciences last closed at $141.25 (-1.55%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 206/738
Valuation grade F
Related stocks
- AbbVieCustomer
Neurocrine의 VMAT2 억제제 Ingrezza 관련 상업화/유통 파트너로 핵심 고객 관계
- Takeda PharmaceuticalCustomer
Neurocrine의 호르몬/신경계 치료제 공동개발·상업화 이력으로 중요한 파트너
- Teva PharmaceuticalCompetitor
틱증·운동장애 및 신경정신과 영역에서 경쟁하는 제약사
ETFs holding this stock
AdvisorShares Psychedelics ETF · iShares Morningstar Small-Cap Growth ETF
Details →About Neurocrine Biosciences
- What technical signals does Neurocrine Biosciences (NBIX) have?
- Neurocrine Biosciences current technical signals: no active technical signal.
- Is Neurocrine Biosciences a cup-and-handle pattern?
- No. Neurocrine Biosciences has no valid Cup signal right now.
- What published figures are available for Neurocrine Biosciences?
- Market cap: $14.08B. Trailing 12 months PER: 20.9×. Latest quarter PBR: 3.98×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Neurocrine Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.